Rekovar Inc.
Lake Forest, CA
Company facts
- SBA certifications
-
Women-Owned Small Business· Current
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 21 Spectrum Pointe Dr #101, Lake Forest, CA 92630, USA
- Website
- rekovar.com
- Founded
- 2018
- Employees
- 1-10
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Health Care Equipment & Services
- Health Care Providers & Services
- Health Care Services
- SIC code
- 80 Health Services
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Vena Vitals Inc. | Irvine, CA | 339112 Surgical and Medical Instrument Manufacturing |
| Rush River Research Corporation | Ellsworth, WI | 541330 Engineering Services |
| Infotech Soft Inc. | Miami, FL | 541511 Custom Computer Programming Services |
| Rhaeos, Inc. | Chicago, IL | — |
| Neurofit, Inc. | Mountain View, CA | 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) |
About the company
Rekovar Inc. is a woman-owned small business based in Lake Forest, California, registered in the System for Award Management (SAM) since November 2018. The company appears to specialize in developing advanced medical technology solutions, with a particular focus on innovative healthcare monitoring devices utilizing artificial intelligence and biosensor technologies. As a corporate entity, Rekovar Inc. has positioned itself as a technological innovator in the healthcare sector, specifically targeting neonatal and pediatric medical challenges.
The company has been awarded multiple federal grants from the National Institute on Drug Abuse (NIDA) focused on developing a wireless wearable monitoring system called NeoMonki for assessing Neonatal Abstinence Syndrome (NAS). These grants, totaling approximately $411,800, support the development of a comprehensive medical monitoring kit that includes wearable wristbands with biosensor technology, a tablet-based healthcare portal, a charging dock station, and an imaging camera. The core innovation of their technology is an AI-driven clinical algorithm designed to continuously monitor and analyze physiological symptoms of newborns experiencing NAS, with the ultimate goal of improving diagnostic precision, reducing hospital stays, and potentially obtaining FDA de novo approval. The grants have supported two primary phases of research and development, with the most recent award in February 2025 focusing on further refining the AI algorithm and conducting clinical trials to validate the NeoMonki system's effectiveness in digital NAS assessment and treatment.
Quick answers
Is Rekovar Inc. registered in SAM.gov?
Yes. Rekovar Inc.'s SAM.gov registration is active through January 1, 2027.
What is Rekovar Inc.'s CAGE code?
Rekovar Inc.'s CAGE code is 87J09, and its Unique Entity ID (UEI) is EJX5YKMCKG35.
Which SBA certifications does Rekovar Inc. hold?
Rekovar Inc. holds Women-Owned Small Business certification from the SBA.
What is Rekovar Inc.'s most recent federal award?
Rekovar Inc.'s most recent federal grant award is Wireless wearable with AI analytics for monitoring neonatal abstinence syndrome (NAS) (R44DA060640), from National Institute on Drug Abuse (NIH), on February 1, 2025.
On GovTribe
See Rekovar Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors